文献速递细菌感染、耐药与抗菌药物医院感染防控

革兰阴性菌血流感染经验性抗生素选择的决策支持模型

Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections.
PubMed 文献 · Clin Microbiol Infect · 2018-04-25

本研究在加拿大和美国开展多中心队列研究,纳入2010年4月至2015年3月住院的革兰阴性菌血流感染患者,开发多变量模型预测抗生素敏感性。模型在革兰染色指导窗口(12个模型,AUC 0.68-0.89)和病原体指导窗口(12个模型,AUC 0.75-0.98)均显示良好区分度,相比抗菌谱指导治疗,决策支持模型有潜力增加窄谱抗生素使用(最高达78%患者)并减少不充分治疗。作者结论认为该模型需进一步前瞻性评估。

要点

  • 多变量模型利用易获取的流行病学因素可预测革兰阴性菌血流感染病原体的抗生素敏感性。
  • 模型在革兰染色指导窗口和病原体指导窗口均显示良好区分度(AUC 0.68-0.98)。
  • 相比抗菌谱指导治疗,决策支持模型有潜力增加窄谱抗生素使用(最高达78%患者)并减少不充分治疗。

核心结论

  • 利用易获取的流行病学因素的多变量模型能以合理区分能力预测感染病原体的抗菌药物敏感性。
  • 实施序贯预测模型进行实时个体化经验性抗生素决策,有潜力优化患者充分覆盖并减少广谱抗生素过度使用,因此需进一步前瞻性评估。

研究设计与样本

  • 在加拿大和美国开展的多中心队列研究,纳入2010年4月至2015年3月住院的革兰阴性菌血流感染患者,共评估1832例患者。

主要发现

  • 多变量模型在两国及两个经验性治疗窗口均显示良好区分度:革兰染色指导窗口12个模型AUC 0.68-0.89,乐观校正后AUC 0.63-0.85;病原体指导窗口12个模型AUC 0.75-0.98,乐观校正后AUC 0.64-0.95。
  • 相比抗菌谱指导治疗,纳入个体患者特征和既往培养结果的抗生素选择决策支持模型有潜力增加窄谱抗生素使用(最高达78%患者)并减少不充分治疗。

关键数值与推荐

  • 决策支持模型基于三个可接受充分覆盖的临床决策阈值(80%、90%和95%)开发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Early empiric antibiotic therapy in patients can improve clinical outcomes in Gram-negative bacteraemia. However, the widespread prevalence of antibiotic-resistant pathogens compromises our ability to provide adequate therapy while minimizing use of broad antibiotics. We sought to determine whether readily available electronic medical record data could be used to develop predictive models for decision support in Gram-negative bacteraemia. METHODS: We performed a multi-centre cohort study, in Canada and the USA, of hospitalized patients with Gram-negative bloodstream infection from April 2010 to March 2015. We analysed multivariable models for prediction of antibiotic susceptibility at two empiric windows: Gram-stain-guided and pathogen-guided treatment. Decision-support models for empiric antibiotic selection were developed based on three clinical decision thresholds of acceptable adequate coverage (80%, 90% and 95%). RESULTS: A total of 1832 patients with Gram-negative bacteraemia were evaluated. Multivariable models showed good discrimination across countries and at both Gram-stain-guided (12 models, areas under the curve (AUCs) 0.68-0.89, optimism-corrected AUCs 0.63-0.85) and pathogen-guided (12 models, AUCs 0.75-0.98, optimism-corrected AUCs 0.64-0.95) windows. Compared to antibiogram-guided therapy, decision-support models of antibiotic selection incorporating individual patient characteristics and prior culture results have the potential to increase use of narrower-spectrum antibiotics (in up to 78% of patients) while reducing inadequate therapy. CONCLUSIONS: Multivariable models using readily available epidemiologic factors can be used to predict antimicrobial susceptibility in infecting pathogens with reasonable discriminatory ability. Implementation of sequential predictive models for real-time individualized empiric antibiotic decision-making has the potential to both optimize adequate coverage for patients while minimizing overuse of broad-spectrum antibiotics, and therefore requires further prospective evaluation. SUMMARY: Readily available epidemiologic risk factors can be used to predict susceptibility of Gram-negative organisms among patients with bacteraemia, using automated decision-making models.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. MacFadden DR, Coburn B, Shah N, et al. Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections. Clin Microbiol Infect. 2018. PMID: 29705558. doi:10.1016/j.cmi.2018.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。